View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 2, 2019

Cognizant’s Protocol Creator transforms clinical trial process

Cognizant has introduced a new SaaS collaboration product, Cognizant Protocol Creator, which helps digitally transform the clinical trial protocol process.

With the new Protocol Creator software, clinical teams will be able to create and review protocol documentation in a purpose-built collaborative environment.

The software simplifies the production of protocol documents and saves time while ensuring quality through the adherence to industry standards.

Cognizant senior vice-president and Life Sciences global head Bhaskar Sambasivan said: “Cognizant Protocol Creator redesigns the entire submission process to be digital first as opposed to one built around antiquated systems that were never intended for writing clinical protocols.

“Not only does it shorten the time to create the protocol and improve its quality, it lays a foundation for a fully digital lab and clinical eco-system that uses automation and artificial intelligence to improve clinical outcomes.”

Protocol Creator aims to obtain a protocol to submission faster and generates clinical trial documentation as a structured document.

Furthermore, using the software, teams can collaborate, manage review cycles and deadlines. It also enables publishing of the final protocol as a traditional document or in machine-readable formats.

Cognizant Accelerator, the company’s product and platform incubator and venture investing division, conceived, validated and developed Cognizant Protocol Creator.

Cognizant Accelerator collaborated with Cognizant Life Sciences to introduce the software to the market.

Cognizant Accelerator vice-president and general manager Todd Paoletti said: “We are firmly focused on delivering transformational products that adopt digital technologies to drive efficiencies throughout an organisation.

“Cognizant Protocol Creator demonstrates this focus, as it plugs a gap in the clinical trial lifecycle that has been, to date, ignored by most technology vendors.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena